Alpha Tau Medical (DRTS) Profit After Tax (2021 - 2026)

Alpha Tau Medical has reported Profit After Tax for 6 years, with the latest figure at $22.9 million in Q1 2026.

• Quarterly Profit After Tax rose 163.94% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.9 million (up 75.22% YoY) and the FY2025 annual result came in at $42.6 million, up 34.26% from the prior year.
• Profit After Tax improved to $22.9 million in Q1 2026 per DRTS's latest filing, from $12.1 million in the prior quarter.
• Over five years, Profit After Tax peaked at $25.7 million in Q1 2022 and troughed at $2.0 million in Q2 2022.
• A 5-year average of $9.4 million and a median of $8.2 million in 2023 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2022 and 2023: Profit After Tax slumped 71.37% in 2022, then soared 334.87% in 2023.
• Over 5 years, Profit After Tax stood at $3.4 million in 2022, then surged by 116.87% to $7.4 million in 2023, then increased by 28.66% to $9.5 million in 2024, then gained by 28.07% to $12.1 million in 2025, then surged by 89.02% to $22.9 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered $22.9 million, $12.1 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.